Ranibizumab in retinopathy of prematurity – one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study

por Stahl, Andreas, Bründer, Marie-Christine, Lagrèze, Wolf A., Molnár, Fanni E., Barth, Teresa, Eter, Nicole, Guthoff, Rainer, Krohne, Tim U., Pfeil, Johanna M.
Publicado 2022

Low-dose AtropIne for Myopia Control in Children (AIM): protocol for a randomised, controlled, double-blind, multicentre, clinical trial with two parallel arms

por Farassat, Navid, Böhringer, Daniel, Küchlin, Sebastian, Molnár, Fanni E, Schwietering, Anne, Seger, Dorina, Hug, Martin J, Knöbel, Anja-Birte, Schneider-Fuchs, Sabine, Ihorst, Gabriele, Wabbels, Bettina, Beisse, Christina, Ziemssen, Focke, Schuettauf, Frank, Hedergott, Andrea, Ring-Mangold, Theresia, Schuart, Claudia, Wolf, Armin, Schmickler, Stefanie, Biermann, Julia, Eberwein, Philipp, Hufendiek, Karsten, Eckstein, Anja, Gusek-Schneider, Gabriele, Schittkowski, Michael, Lischka, Thomas, Lagrèze, Wolf A
Publicado 2023